Natural health product · NPN 80135641
NMN
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed November 4, 2024; licence last revised March 4, 2026.
- Natural Product Number (NPN)
- 80135641
- Licence holder
- Novus Creatus LLC
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Compendial
- First licensed
- November 4, 2024
- Licence last revised
- March 4, 2026
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| 3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium | 500 mg |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health. NMN is a NAD+ precursor which is a factor in normal growth and development. NMN is a NAD+ precursor which is an important cofactor in energy metabolism. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Supports biological functions which play a key role in the maintenance of good health.
Non-medicinal ingredients
Hydroxypropyl Methylcellulose; Magnesium stearate; Microcrystalline cellulose; Silicon dioxide